Vectors in gene therapy

Results: 27



#Item
11

PDF Document

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2012-09-11 07:19:00
12General Retroviral Vector Questions 1. Is there information on the number of independent integration events in the transduced cell population? 2 Is there information 2.

General Retroviral Vector Questions 1. Is there information on the number of independent integration events in the transduced cell population? 2 Is there information 2.

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-14 10:31:55
13CALIFORNIA STATE SCIENCE FAIR 2011 PROJECT SUMMARY Name(s)  Irving Diaz; Tracy Ly

CALIFORNIA STATE SCIENCE FAIR 2011 PROJECT SUMMARY Name(s) Irving Diaz; Tracy Ly

Add to Reading List

Source URL: www.usc.edu

Language: English - Date: 2011-04-30 00:46:22
14Informed Consents for Clinical T i l Using Trials U i Integrating I i Vectors

Informed Consents for Clinical T i l Using Trials U i Integrating I i Vectors

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 13:18:12
15CTGTAC #41, Topic II, NTP  Introduction Retroviral vectors represent both the first viral vector system used for clinical gene transfer, as well as one of the most widely used in clinical trials to date. The replication

CTGTAC #41, Topic II, NTP Introduction Retroviral vectors represent both the first viral vector system used for clinical gene transfer, as well as one of the most widely used in clinical trials to date. The replication

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-02-02 08:50:24
16Microsoft Word - Document2

Microsoft Word - Document2

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-08 15:04:27
17First National Gene Transfer Safety Symposium: Internally Deleted, Helper-Dependent Adenoviral Vectors March 8, 2000 INTRODUCTION In March 2000, as part of ongoing efforts to enhance the protection of research participan

First National Gene Transfer Safety Symposium: Internally Deleted, Helper-Dependent Adenoviral Vectors March 8, 2000 INTRODUCTION In March 2000, as part of ongoing efforts to enhance the protection of research participan

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 12:40:23
18Periodic surveillance of rDNA activities by the IBC ________________________________ Human gene therapy trials A. Changes in vectors or inserts

Periodic surveillance of rDNA activities by the IBC ________________________________ Human gene therapy trials A. Changes in vectors or inserts

Add to Reading List

Source URL: osp.od.nih.gov

- Date: 2014-01-08 15:12:45
    19Current Drug Delivery, 2011, 8, [removed]Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions Mahmoud Elsabahy1, Adil Nazarali2 and Marianna Foldvari1,*

    Current Drug Delivery, 2011, 8, [removed]Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions Mahmoud Elsabahy1, Adil Nazarali2 and Marianna Foldvari1,*

    Add to Reading List

    Source URL: www.usask.ca

    Language: English - Date: 2014-10-27 09:22:56
    20Informed Consents for Clinical T i l Using Trials U i Integrating I i Vectors

    Informed Consents for Clinical T i l Using Trials U i Integrating I i Vectors

    Add to Reading List

    Source URL: osp.od.nih.gov

    Language: English - Date: 2014-01-09 12:09:34